The Research Foundation for the State University of New York
发明人:
申请号：
EP14820357.3
公开号：
EP3016660A4
申请日:
2014.07.01
申请国别(地区):
EP
年份:
2017
代理人:
摘要：
The present invention relates to the use of SHIP1 inhibitors and pan-SHIP1/2 inhibitors in various methods, including, without limitation: (i) a method to treat obesity or reduce body fat of an obese subject； (ii) a method to limit bone development in a subject suffering from an osteopetrotic or sclerotic disease； (iii) a method to treat or prevent diabetes； (iv) a method to reduce glucose intolerance or insulin resistance； and (v) a method to lower cholesterol.
